1
.
Prevnar 13
Pneumococcal 13-valent Conjugate
Vaccine [Diphtheria CRM197 Protein]
.
2
Names and Abbreviations
 Prevnar 13
 Pneumococcal 13-valent Conjugate
Vaccine [Diphtheria CRM197 Protein]
 13-valent ...
3
Prevnar 13
 Each 0.5 mL dose contains:
 2.2 µg of saccharide from each of pneumococcal serotypes 1, 3,
4, 5, 6A, 7F, 9...
4
Proposed Indication
For the prevention of Invasive disease
Meningitis and Otitis media caused by
Streptococcus pneumonia...
of 4

Prevnar

Published on: Mar 4, 2016
Published in: Healthcare      
Source: www.slideshare.net


Transcripts - Prevnar

  • 1. 1 . Prevnar 13 Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein] .
  • 2. 2 Names and Abbreviations  Prevnar 13  Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]  13-valent pneumococcal conjugate vaccine  13vPnC  PCV13
  • 3. 3 Prevnar 13  Each 0.5 mL dose contains:  2.2 µg of saccharide from each of pneumococcal serotypes 1, 3, 4, 5, 6A, 7F, 9V, 14, 18C, 19A, 19F, and 23F  4.4 µg of saccharide from pneumococcal serotype 6B  32 µg of CRM197 carrier protein  0.125 mg Aluminum as AlPO4 adjuvant  0.02% polysorbate 80  5mM succinate buffer  Single-dose, pre-filled syringe  Intramuscular administration  4 dose series at 2, 4, 6, and 12-15 months of age.  Store at 2 to 8°C / 36 to 46°F (refrigerate – do not freeze)
  • 4. 4 Proposed Indication For the prevention of Invasive disease Meningitis and Otitis media caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F in infants and toddlers.

Related Documents